Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Retinal neovascularization is a major cause of blindness and requires the activities of several signaling pathways and multiple cytokines. Activation of protein kinase C (PKC) enhances the angiogenic process and is involved in the signaling of vascular endothelial growth factor (VEGF). We have demonstrated a dramatic increase in the angiogenic response to oxygen-induced retinal ischemia in transgenic mice overexpressing PKCβ2 isoform and a significant decrease in retinal neovascularization in PKCβ isoform null mice. The mitogenic action of VEGF, a potent hypoxia-induced angiogenic factor, was increased by 2-fold in retinal endothelial cells by the overexpression of PKCβ1 or β2 isoforms and inhibited significantly by the overexpression of a dominant-negative PKCβ2 isoform but not by the expression of PKC α, δ, and ζ isoforms. Association of PKCβ2 isoform with retinoblastoma protein was discovered in retinal endothelial cells, and PKCβ2 isoform increased retinoblastoma phosphorylation under basal and VEGF-stimulated conditions. The potential functional consequences of PKCβ-induced retinoblastoma phosphorylation could include enhanced E2 promoter binding factor transcriptional activity and increased VEGF-induced endothelial cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, within the TME, PKC beta, another PKC isoform, is a well‐documented effector of the VEGF signaling that promotes angiogenesis and is required for invasiveness in certain tumors, such as pancreatic tumors [122, 123, 124].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [123]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Self-citationKim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Oxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Self-citationAmelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Self-citationAiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
Self-citationJiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Self-citationTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Research works printed but not linked: 2
- L E Smith, E Wesolowski, A McLellan, S K Kostyk, R D'Amato, R Sullivan, P A D'Amore Invest Ophthalmol Visual Sci 35, 101–111 (1994).
- T Sakamoto, T Ishibashi, H Kimura, H Yoshikawa, C Spee, M S Harris, D R Hinton, S J Ryan Invest Ophthalmol Visual Sci 36, 1076–1083 (1995).
Cited by
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Seminal studies by the Joslin group (201, 327, 328) and others (382) have emphasized the central role of PKC- in particular PKC- I and - II, in various diabetic complications including nephropathy, retinopathy, and cardiac dysfunction (384, 572, 627).”
BackgroundActivation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
Self-citationProtein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Rask-Madsen, C., & King, G. L. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.012 · Cited by 846
Self-citationDiabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
“neovascularization is suppressed in animals with reduced PKCβ levels (45,46).”
BackgroundSelf-citationEfficient assembly of nanopore reads via highly accurate and intact error correction
Chen, Y., Nie, F., Xie, S.-Q., Zheng, Y.-F., Dai, Q., Bray, T., Wang, Y.-X., Xing, J.-F., Huang, Z.-J., Wang, D.-P., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20236-7 · Cited by 446
Geraldes, P., Hiraoka-Yamamoto, J., Matsumoto, M., Clermont, A., Leitges, M., Marette, A., Aiello, L. P., Kern, T. S., & King, G. L. (2009) · Nature Medicine · doi:10.1038/nm.2052 · Cited by 425
Self-citationTumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Simó, R., Sundstrom, J. M., & Antonetti, D. A. (2014) · Diabetes Care · doi:10.2337/dc13-2002 · Cited by 280
“tion (36), likely involving activation of extracellular regulated kinase pathway.”
BackgroundEffect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
Self-citationRobertson, M. J., Kahl, B. S., Vose, J. M., de Vos, S., Laughlin, M., Flynn, P. J., Rowland, K., Cruz, J. C., Goldberg, S. L., Musib, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3146 · Cited by 232
Diabetic macular edema: new concepts in patho-physiology and treatment
Zhang, X., Zeng, H., Bao, S., Wang, N., & Gillies, M. C. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-27 · Cited by 230
“The regulation of VEGF-A gene expression has been shown to be controlled and enhanced by PKC-β in a transgenic mouse model [66].”
BackgroundHeine, V. M., Zareno, J., Maslam, S., Joëls, M., & Lucassen, P. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03951.x · Cited by 225
Naruse, K., Rask-Madsen, C., Takahara, N., Ha, S.-W., Suzuma, K., Way, K. J., Jacobs, J. R. C., Clermont, A. C., Ueki, K., Ohshiro, Y., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0771 · Cited by 220
“The creation of FVB mice with a PKC 2 transgene under control of the prepro-endothelin promoter (PKC 2Tg), resulting in overexpression of PKC 2 in endothelial cells and vascular smooth muscle cells, has been described previously (16).”
BackgroundSelf-citationThe PKC-DRS Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2188 · Cited by 218
Chinnam, M., & Goodrich, D. W. (2011) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00005-x · Cited by 199
“…the p38 stress activated kinase 1 (Hou et al., 2002; Nath et al., 2003), ERK1/2 (Guo et al., 2005), AMP-activated protein kinase (Dasgupta et al., 2009), protein kinase C beta (Suzuma et al., 2002), Aurora B (Nair et al., 2009), Chk1/2 (Inoue et al., 2007), and Raf-1 (Dasgupta et al., 2004).”
BackgroundMolecular mechanisms of diabetic vascular complications
Kitada, M., Zhang, Z., Mima, A., & King, G. L. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00018.x · Cited by 193
Self-citationOxidative Stress‐Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy
Li, C., Miao, X., Li, F., Wang, S., Liu, Q., Wang, Y., & Sun, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9702820 · Cited by 184
Yonghua, Z., Kunlin, J., Ou Mao, X., & Greenberg, D. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0515com · Cited by 180
Microvascular complications of diabetes
He, Z., & King, G. L. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2003.12.003 · Cited by 169
Self-citationMurakami, T., Frey, T., Lin, C., & Antonetti, D. A. (2012) · Diabetes · doi:10.2337/db11-1367 · Cited by 167
“The clinical data have been supported by experimental evidence reporting that this inhibitor reduces VEGF-induced vascular permeability and neovascularization (10,11).”
MethodThe Potential Role of PKC β in Diabetic Retinopathy and Macular Edema
Aiello, L. P. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00391-0 · Cited by 165
Self-citationLutzny, G., Kocher, T., Schmidt-Supprian, M., Rudelius, M., Klein-Hitpass, L., Finch, A. J., Dürig, J., Wagner, M., Haferlach, C., Kohlmann, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.003 · Cited by 156
“Previously, activation of PKC-bII in endothelial cells was observed as a response to hypoxia in a nontumor mouse model and was required for neovascularization (Suzuma et al., 2002).”
Self-citationAiello, L. P., Clermont, A. C., Arora, V. M., Davis, M. D., Sheetz, M. J., & Bursell, S. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0757 · Cited by 168
Self-citationLeptin Stimulates Ischemia-Induced Retinal Neovascularization
Suganami, E., Takagi, H., Ohashi, H., Suzuma, K., Suzuma, I., Oh, H., Watanabe, D., Ojima, T., Suganami, T., Fujio, Y., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2443 · Cited by 141
Self-citationE2F1 transcription factor and its impact on growth factor and cytokine signaling
Ertosun, M. G., Hapil, F. Z., & Özeş, O. N. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.001 · Cited by 146
Tumor microenvironment (TME)-driven immune suppression in B cell malignancy
Nicholas, N. S., Apollonio, B., & Ramsay, A. G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.003 · Cited by 143
Protein kinase C signaling and cell cycle regulation
Black, A. R., & Black, J. D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00423 · Cited by 125
“Effects in G1 have been ascribed to the ability of PKCβII to enhance transcription of cyclin D1 (Li and Weinstein, 2006), promote pRb phosphorylation (Suzuma et al., 2002), or to stimulate CAK activity through direct phosphorylation (Acevedo-Duncan et al., 2002).”
BackgroundClassical PKC isoforms in cancer
Martiny‐Baron, G., & Fabbro, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.001 · Cited by 139
“[40] Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K, Leitges M, et al.”
BackgroundOvercoming cold tumors: a combination strategy of immune checkpoint inhibitors
Ouyang, P., Wang, L., Wu, J., Tian, Y., Chen, C., Li, D., Yao, Z., Chen, R., Xiang, G., Gong, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1344272 · Cited by 137
Ramana, K. V., Friedrich, B. M., Tammali, R., West, M., Bhatnagar, A., & Sk, S. (2005) · Diabetes · doi:10.2337/diabetes.54.3.818 · Cited by 133
Javaid, K., Rahman, A., Anwar, K. N., Frey, R. S., Minshall, R. D., & Malik, A. B. (2003) · Circulation Research · doi:10.1161/01.res.0000072971.88704.cb · Cited by 124
The PKCβ/HuR/VEGF pathway in diabetic retinopathy
Amadio, M., Bucolo, C., Leggio, G. M., Drago, F., Govoni, S. M., & Pascale, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.033 · Cited by 117
Bai, Y., Bai, X., Wang, Z., Zhang, X., Ruan, C., & Miao, J. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.04.016 · Cited by 113
“It has been known that activation of p38, ERK, protein kinase C (PKC) or stat3 is involved in the angiogenic process or ischemia retinal NV (Chrzanowska-Wodnicka et al., 2008; Suzuma et al., 2002; Mechoulam and Pierce, 2005).”
BackgroundMinami, T., Abid, M. R., Zhang, J., King, G., Kodama, T., & Aird, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208974200 · Cited by 109
Self-citationProtein kinase C in enhanced vascular tone in diabetes mellitus
Kizub, I. V., Klymenko, K., & Soloviev, A. I. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.117 · Cited by 115
“As it has been shown in retinal endothelium, PKC-βII activation may result in induction of VEGF which induces angiogenesis [99, 101], and increases permeability of endothelial cells [102, 103] and SMCs [104].”
BackgroundGlomerular VEGF resistance induced by PKCδ/SHP‐1 activation and contribution to diabetic nephropathy
Mima, A., Kitada, M., Geraldes, P., Li, Q., Matsumoto, M., Mizutani, K., Qi, W., Li, C., Leitges, M., Rask‐Madsen, C., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-202994 · Cited by 104
“These adenoviral vectors were used to infect podocytes reported previously (14).”
MethodSelf-citationThe role of calcium in hypoxia-induced signal transduction and gene expression
Seta, K. A., Yuan, Y., Spicer, Z., Lü, G., Bedard, J. E. J., Ferguson, T., Pathrose, P., Cole-Strauss, A., Kaufhold, A., & Millhorn, D. E. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.02.006 · Cited by 111
Proliferative Diabetic Retinopathy
Shah, K. B., & Han, D. P. (2004) · International Ophthalmology Clinics · doi:10.1097/00004397-200404440-00007 · Cited by 97
Davis, M. D., Sheetz, M. J., Aiello, L. P., Milton, R. C., Danis, R. P., Zhi, X., Girach, A., Jimenez, M. C., & Vignati, L. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2473 · Cited by 87
Self-citationResponding to Hypoxia: Lessons From a Model Cell Line
Seta, K. A., Spicer, Z., Yuan, Y., Lu, G., & Millhorn, D. E. (2002) · Science's STKE · doi:10.1126/stke.2002.146.re11 · Cited by 80
“For instance, activation of PKC enhances the angiogenic process, and PKC is involved in the signaling of VEGF in retinal cells exposed to hypoxia (119).”
BackgroundProtein Kinase C (PKC ): Nomal Functions and Dieases
Kawakami, T., Kawakami, Y., & Kitaura, J. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003273 · Cited by 80
Ojima, T., Takagi, H., Suzuma, K., Oh, H., Suzuma, I., Ohashi, H., Watanabe, D., Suganami, E., Murakami, T., Kurimoto, M., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050435 · Cited by 82
Self-citationWatanabe, D., Takagi, H., Suzuma, K., Suzuma, I., Oh, H., Ohashi, H., Kemmochi, S., Uemura, A., Ojima, T., Suganami, E., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63741-8 · Cited by 75
Self-citationThe role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy
Curtis, T. M., & Scholfield, C. N. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.431 · Cited by 74
Titchenell, P. M., & Antonetti, D. A. (2013) · Diabetes · doi:10.2337/db12-1744 · Cited by 70
He, Z., Way, K. J., Arikawa, E., Chou, E. L., Opland, D. M., Clermont, A. C., Isshiki, K., Ronald, C. W., Scott, J. A., Schöen, F. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413493200 · Cited by 67
Self-citationVascular Endothelial Growth Factor Induces MEF2C and MEF2-Dependent Activity in Endothelial Cells
Maiti, D., Xu, Z., & Duh, E. J. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1760 · Cited by 67
“We were interested in testing the possible effects of specific PKC isoforms, particularly PKC- given its known effects in mediating VEGF action in retinal endothelial cells and its effects on retinal neovascularization.(44) We found that VEGF induction of MEF2C expression was significantly reduced by the inhibition of…”
BackgroundKumar, B., Gupta, S. K., Srinivasan, B. P., Nag, T. C., Srivastava, S., & Saxena, R. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.007 · Cited by 65
Joy, S. V., Scates, A. C., Bearelly, S., Dar, M. S., Taulien, C. A., Goebel, J. A., & Cooney, M. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e572 · Cited by 65
The Calcium Signaling Mechanisms in Arterial Smooth Muscle and Endothelial Cells
Ottolini, M., & Sonkusare, S. K. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200030 · Cited by 64
LncRNA VEAL2 regulates PRKCB2 to modulate endothelial permeability in diabetic retinopathy
Sehgal, P., Mathew, S., Sivadas, A., Ray, A., Tanwar, J., Vishwakarma, S., Ranjan, G., Vellarikkal, S. K., Bhoyar, R. C., Pateria, A., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020107134 · Cited by 61
“Role of PRKCB2 has been particularly investigated in the context of hyperglycemia and subsequent retinopathy involving excessively permeable eye vasculature (Suzuma et al , 2002).”
Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research
Donnelly, R., Idris, I., & Forrester, J. V. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.88.1.145 · Cited by 63
“23 In addition, use of a specific PKC-b inhibitor confirms that this isozyme is particularly important in VEGF mediated responses, including the effects of VEGF on the blood-retinal barrier leading to macular oedema formation.”
BackgroundCellular oxygen sensing, signalling and how to survive translational arrest in hypoxia
Fähling, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01894.x · Cited by 57
Diabetic Retinopathy: Important Biochemical Alterations and the Main Treatment Strategies
Valdez-Guerrero, A. S., Quintana-Pérez, J. C., Arellano-Mendoza, M. G., Ibarra, F. C., Cach, F. T., & Alemán-González-Duhart, D. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.10.009 · Cited by 59
The Retinoblastoma Family Proteins Bind to and Activate Diacylglycerol Kinaseζ
Los, A. P., Vinke, F. P., de Widt, J., Topham, M. K., BLITTERSWIJK, W. J. V., & Divecha, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502693200 · Cited by 59
PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma
Yang, L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i1.35 · Cited by 57
The therapeutic role of targeting protein kinase C in solid and hematologic malignancies
Podar, K., Raab, M. S., Chauhan, D., & Anderson, K. C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1693 · Cited by 56
“In addition to their direct effects on tumor cells, PKC and PKCβ signaling pathways are also linked to VEGF- and 12O -tetradecanoylphorbol 13-acetate-triggered angiogenesis [80-85] .”
BackgroundYoung, T. A., Wang, H., Munk, S., Hammoudi, D. S., Young, D. S., Mandelcorn, M. S., & Whiteside, C. I. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.11.015 · Cited by 57
A non-invasive, multi-target approach to treat diabetic retinopathy
Julius, A., & Hopper, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.185 · Cited by 50
Protein kinase C signaling “in” and “to” the nucleus: Master kinases in transcriptional regulation
Kazanietz, M. G., & Cooke, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105692 · Cited by 51
“This action is mediated by enhanced retinoblastoma protein phosphorylation and the subsequent dissociation of Rb – E2F complexes leading to increased E2F activation (110).”
BackgroundEmerging roles of PLCγ1 in endothelial biology
Chen, D., & Simons, M. (2021) · Science Signaling · doi:10.1126/scisignal.abc6612 · Cited by 49
“Furthermore, overexpression of PKC2 (but not of PKC, PKC, or PKC) induces proliferation and migration of bovine retinal endothelial cells, whereas overexpression of a dominant-negative form of PKC2 decreases both processes (141).”
BackgroundKinkade, R., Dasgupta, P., Carie, A., Pernazza, D., Carless, M. A., Pillai, S., Lawrence, N. J., Sebti, S. M., & Chellappan, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6672 · Cited by 52
“Given the published reports that Raf-1 kinase contributes to angiogenesis and that VEGF can induce Rb phosphorylation, it is likely that RRD-251 is inhibiting angiogenesis by affecting these molecules (31, 46 ).”
BackgroundClinical safety of the selective PKC-β inhibitor, ruboxistaurin
McGill, J. B., King, G. L., Berg, P. H., Price, K. L., Kles, K. A., Bastyr, E. J., & Hyslop, D. L. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.6.835 · Cited by 48
“THE PKC-DRS STUDY GROUP: The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the PKC-DRS multicenter randomized clinical trial.”
BackgroundSelf-citationInvolvement of RB gene family in tumor angiogenesis
Gabellini, C., Del Bufalo, D., & Zupi, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209631 · Cited by 47
“…VEGF may induce neurogenesis with a mechanism similar to the one observed during VEGF-stimulated proliferation of endothelial cells, including an increase of cyclin D1 expression, CDK4 kinase activity, pRb phosphorylation and E2F promoter activity (Pedram et al., 1998, 2001; Suzuma et al., 2002).”
BackgroundChen, Y., & LaCasce, A. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.6.939 · Cited by 53
“Drugs (2008) 17(6) PKCβ participates in vascular endothelial growth factor (VEGF) signaling [10,11] , regulates progression through the cell cycle, and communicates with the phosphoinositide-3 kinase/AKT (PI3K/AKT) pathway, which regulates apoptosis [12] .”
BackgroundProtein kinase C β inhibition: a novel therapeutic strategy for diabetic microangiopathy
IDRIS, I. R., & Donnelly, R. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.026 · Cited by 53
Hernández, C., & Simó, R. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.8.1209 · Cited by 52
“The mechanism of the mitogenic activity of PKCβ isoform includes the activation of ERK and phosphorylation of retinoblastoma protein [49] .”
BackgroundBenhadji, K. A., Serova, M., Ghoul, A., Cvitkovic, E., Tourneau, C. L., Ogbourne, S. M., Lokiec, F. M., Calvo, F. M., Hammel, P. R., Faivre, S. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604642 · Cited by 46
Evangelisti, C., Tazzari, P. L., Riccio, M., Fiume, R., Hozumi, Y., Falà, F., Goto, K., Manzoli, L., Cocco, L., & Martelli, A. M. (2007) · The FASEB Journal · doi:10.1096/fj.07-8336com · Cited by 45
“As stated above, PKC-II directly phosphorylates pRB; however, the phosphorylative events do not involve Ser-807/811 ( 29 ).”
BackgroundImmunomodulatory Drugs for the Treatment of B Cell Malignancies
Ioannou, N., Jain, K., & Ramsay, A. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168572 · Cited by 43
Protein Kinase C: An Attractive Target for Cancer Therapy
Marengo, B., Ciucis, C. D., Ricciarelli, R., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2011) · Cancers · doi:10.3390/cancers3010531 · Cited by 48
“tissue [56].”
PKC-ɛ inhibition: a new therapeutic approach for diabetic complications?
Avignon, A., & Sultan, A. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70270-7 · Cited by 40
“The mitogenic action of VEGF is also increased by 2-fold in retinal endothelial cells of animals that overexpress PKC-βI or -βII isoforms and is significantly inhibited by the overexpression of a dominant-negative PKC-βII isoform; overexpression of the PKC-α, -δ, and -ζ isoforms do not, however, alter VEGF function [1…”
BackgroundResearch progress on the mechanism of ferroptosis and its role in diabetic retinopathy
He, W., Lu, C., Li, X., & Mei, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1155296 · Cited by 47
Chen, Y., Nie, F., Xie, S., Zheng, Y., Bray, T., Dai, Q., Wang, Y.-X., Xing, J.-F., Huang, Z., Wang, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.01.930107 · Cited by 38
Yao, Y., Yang, H. S., Cao, Z., Danielsson, J. A., & Duh, E. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.017 · Cited by 37
“Moreover, mice transgenic for the PKCb2 isoform develop a dramatic increase in retinal neovascularization in the oxygen-induced retinopathy model, whereas PKCb knockout mice demonstrate a significant decrease in retinal neovascularization [37].”
BackgroundBansode, R. R., Leung, T., Randolph, P. D., Williams, L. L., & Ahmedna, M. (2012) · Food Science & Nutrition · doi:10.1002/fsn3.13 · Cited by 36
“Vascular endothelial growth factor (VEGF) is a potent angiogenic factor that is induced by hypoxia and plays a central role in the development of neovascularization in multiple diseases, including tumor growth (Suzuma et al. 2002).”
BackgroundSheetz, M. J., Aiello, L. P., Shahri, N., Davis, M. D., Kles, K. A., & Danis, R. P. (2011) · Retina · doi:10.1097/iae.0b013e3181fe545f · Cited by 35
Self-citationSecretogranin III: a diabetic retinopathy-selective angiogenic factor
Li, W., Webster, K. A., LeBlanc, M. E., & Tian, H. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2635-5 · Cited by 32
Zhang, H., Gao, Y., Zhang, J., Wang, K., Jin, T., Wang, H., Ruan, K., Wu, F. H., & Xu, Z. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112773 · Cited by 33
Diabetic retinopathy: emerging concepts of current and potential therapy
Sadikan, M. Z., & Nasir, N. A. A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02599-y · Cited by 34
“PKC activation stimulates VEGF production in DR (Aiello et al. 1997; Suzuma et al. 2002; Abdul Ghani et al. 2023).”
Absolute Quantitation of Isoforms of Post-translationally Modified Proteins in Transgenic Organism
Li, Y.-J., Shu, Y., Peng, C., Zhu, L., Guo, G., & Li, N. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016568 · Cited by 32
Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?
Seystahl, K., & Weller, M. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.670219 · Cited by 31
Protein Kinase C Beta in the Tumor Microenvironment Promotes Mammary Tumorigenesis
Wallace, J. A., Pitarresi, J. R., Sharma, N., Palettas, M. S., Cuitiño, M. C., Sizemore, S. T., Yu, L., Sanderlin, A. G., Rosol, T. J., Mehta, K. D., et al. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00087 · Cited by 31
Ivanova, I. A., D’Souza, S. J. A., & Dagnino, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208999 · Cited by 37
“The PKCzencoding adenovirus was a gift from G King (Suzuma et al., 2002).”
BackgroundMethodDiabetic macular edema: New promising therapies
Shamsi, H. N. A., Masaud, J. S., & Ghazi, N. G. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i6.324 · Cited by 28
Mechanism of Action of the Angiostatic Cortisene Anecortave Acetate
Clark, A. F. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.11.003 · Cited by 28
Hasegawa, H., Nakano, T., Hozumi, Y., Takagi, M., Ogino, T., Okada, M., Iseki, K., Kondo, H., Watanabe, M., Martelli, A. M., et al. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21873 · Cited by 27
“Moreover, phosphorylation of Ser-807/811 led to an inactivation of pRB tumor suppressor activity in uveal melanoma [Brantley and Harbour, 2000], suggesting that these two residues are key determinants of pRB activity.”
BackgroundInfluentialThe Protein Kinase C Inhibitor: Ruboxistaurin
Deissler, H. L., & Lang, G. E. (2015) · Developments in ophthalmology · doi:10.1159/000431204 · Cited by 28
Bokhari, S. M., Zhou, L. Y., Karasek, M. A., Paturi, S. G., & Chaudhuri, V. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700071 · Cited by 27
Emerging role of protein kinase C in energy homeostasis: A brief overview
Mehta, K. D. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.385 · Cited by 27
Chegini, S. P., Varshosaz, J., Hamid, M., Dehghani, A., & Minayian, M. (2019) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2019.0002 · Cited by 25
Characterization of a Novel Protein Kinase D
Feng, H., Ren, M., Wu, S.-L., Hall, D. H., & Rubin, C. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511899200 · Cited by 25
Aiello, L. P., Cahill, M. T., & Cavallerano, J. D. (2004) · Eye · doi:10.1038/sj.eye.6700585 · Cited by 26
Self-citationProtein kinase C inhibits binding of diacylglycerol kinase-ζ to the retinoblastoma protein
Los, A. P., de Widt, J., Topham, M. K., BLITTERSWIJK, W. J. V., & Divecha, N. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.12.004 · Cited by 24
MicroRNA (miRNA) in the Pathogenesis of Diabetic Retinopathy: A Narrative Review
Lampsas, S., Agapitou, C., Chatzirallis, A., Papavasileiou, G. E., Poulakis, D., Pegka, S., THEODOSSIADIS, P. G., Lambadiari, V., & Chatziralli, I. (2025) · Genes · doi:10.3390/genes16091060 · Cited by 27
PKCη associates with cyclin E/Cdk2 complex in serum-starved MCF-7 and NIH-3T3 cells
Shtutman, M., Hershko, T., Maissel, A., Fima, E., & Livneh, E. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00087-9 · Cited by 22
Higuchi, A., Yamada, H., Yamada, E., Jo, N., & Matsumura, M. (2011) · PubMed Central · doi:10.6084/m9.figshare.73865 · Cited by 21
Deissler, H. L., Deißler, H., & Lang, G. E. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3917 · Cited by 22
Metadata
- Authors
- Suzuma, K., Takahara, N., Suzuma, I., Isshiki, K., Ueki, K., Leitges, M., Aiello, L. P., & King, G. L.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- King, George L.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-01-22
- Volume
- 99
- Issue
- 2
- Pages
- 721-726
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC117372
- OpenAlex
- W1992451339
- Cited by
- 170
- References
- 33
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 7 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 10 · 2013: 8 · 2012: 8
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- National Institutes of Health (5r29ey010827-04, 5r01ey005110-18)
- National Eye Institute (R01 EY5110, EY10827)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- protein kinase C beta, retinoblastoma protein phosphorylation, retinal neovascularization, vascular endothelial growth factor, endothelial cell proliferation, angiogenesis, retinal endothelial cells, hypoxia
- MeSH terms
- Animals, Cattle, Cell Division, Cells, Cultured, DNA-Binding Proteins, Endothelium, Vascular, Isoenzymes, Lymphokines, Mice, Inbred C57BL, Mice, Transgenic, Neovascularization, Pathologic, Phosphorylation, Protein Kinase C, Retinal Vessels, Transcription Factors, Signal Transduction, Retinoblastoma Protein, Endothelial Growth Factors, Mice, Knockout, Cell Cycle Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, E2F Transcription Factors, Mice, Protein Kinase C beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.